Posted inGenetics Smarter Cell Culture Starts with Better Media September 10, 2026 As a graduate student in the early 1980s, part of my funding came through a research assistantship in a cell-culture…
Posted inGenetics CAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research Collaboration September 10, 2026 Chimeric antigen receptor (CAR) T cells (blue and yellow) being used to treat prostate cancer (light blue, nodular), illustration. [Nemes…
Posted inGenetics Revvity Signs Agreement to Acquire Human Cell Design September 10, 2026 Credit: Janie Chros/Getty Images Revvity inked a deal to acquire Human Cell Design (HCD), a France-based biotechnology company specializing in…
Posted inGenetics Top 10 Contract Development and Manufacturing Organizations 2026 September 10, 2026 A survey of more than 300 biopharma leaders published in August by McKinsey delivered some good news for contract development…
Posted inGenetics 10 CDMO Up & Comers 2026 September 10, 2026 Below are 10 contract development and manufacturing organizations (CDMOs) listed by GEN as Up & Comers for making headlines with…
Posted inGenetics The Emerging Power of Mass Spectrometry in Oncology September 9, 2026 Mass spectrometry allows for the identification and quantification of a wide range of molecules from small metabolites to larger proteins.…
Posted inGenetics Gene Therapy Extends Lifespan and Reduces Symptoms in Sandhoff Disease Cat Model September 9, 2026 Credit: Thom Leach / Science Photo Library / Getty Images Sandhoff disease, like Tay-Sachs disease, is a fatal neurodegenerative lysosomal…
Posted inGenetics Monoclonal Antibodies Targeting MMP-9 Alleviate Peripheral Neuropathy in Diabetic Mice September 9, 2026 Credit: Evgenyi_Eg / iStock / Getty Images Plus Diabetic peripheral neuropathy (DPN) describes nerve damage in the hands, legs, and…
Posted inGenetics Increasing CHO Cell Productivity September 9, 2026 Overexpressing the cytoplasmic poly(A)-binding protein gene Pabpc1 increases protein titers in Chinese hamster ovary (CHO) cell lines by 30–50%, according…
Posted inGenetics No One-Size-Fits-All Solution for Autologous Cell Therapy Manufacturing September 9, 2026 Autologous cell therapy production is difficult from an operational standpoint, according to researchers, who say choosing a manufacturing model that…